Nivolumab for adjuvant treatment of desmoplastic malignant melanoma: A case report

J Dermatol. 2020 Jan;47(1):e6-e7. doi: 10.1111/1346-8138.15134. Epub 2019 Nov 7.

Authors

Tomoyuki Shibata¹, Nobuhiko Iwashita¹, Hiroyuki Takama¹, Takeshi Yanagishita¹, Tomohiro Takeo¹, Yuichiro Oshima¹, Daisuke Watanabe¹, Toyonori Tsuzuki²

Affiliations

¹ Department of Dermatology, Aichi Medical University School of Medicine, Nagakute, Japan.
² Department of Pathology, Aichi Medical University School of Medicine, Nagakute, Japan.

PMID: 31701575
DOI: 10.1111/1346-8138.15134

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adjuvants, Immunologic / therapeutic use*
Aged
Antineoplastic Agents, Immunological / therapeutic use*
Female
Humans
Melanoma / diagnosis
Melanoma / drug therapy*
Melanoma / radiotherapy
Melanoma / surgery
Nivolumab / therapeutic use*
Skin Neoplasms / diagnosis
Skin Neoplasms / drug therapy*
Skin Neoplasms / radiotherapy
Skin Neoplasms / surgery

Substances

Adjuvants, Immunologic
Antineoplastic Agents, Immunological
Nivolumab